SPOTLIGHT: FDA gives nod to Ranbaxy's generic Diovan


India's Ranbaxy Laboratories got a tentative FDA OK for a generic version of the Novartis drug Diovan, used to treat high blood pressure and heart failure. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.